Creatv Bio, a division of Creatv Microtech, Inc. w
Post# of 154625

Bria Cell stock rises on Positive Survival Data from Study in Cancer Patients: Retail gets more bullish.
HR+metastic breast cancer patients treated with Bria-IMT plus check point inhibitors... had a median overal survival (OS) of 17.3 months, exceeding the 14.4 months achieved with Trodelvy... in similar heavily pre-treated patients.
I wonder if Bria will be at the ESMO Conference?

